Ovarian cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 488: | Line 488: | ||
* appendicolith may be visualized. | * appendicolith may be visualized. | ||
| style="background: #F5F5F5; padding: 5px;" |NA | | style="background: #F5F5F5; padding: 5px; text-align: center;" |NA | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Imaging/history | * Imaging/history | ||
Line 498: | Line 498: | ||
* 60-70 y/o for adenocarcinoma, | * 60-70 y/o for adenocarcinoma, | ||
* 30-50 y/o for carcinoid tumors | * 30-50 y/o for carcinoid tumors | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* In adenocarcinoma type we may have high levels of CEA and CA 19-9 | * In adenocarcinoma type we may have high levels of CEA and CA 19-9 | ||
Line 533: | Line 533: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Diverticular abscess]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Diverticular abscess]] | ||
| style="background: #F5F5F5; padding: 5px;" |>50 y/o | | style="background: #F5F5F5; padding: 5px; text-align: center;" |>50 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" |+ | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Leukocytosis | * Leukocytosis | ||
Line 554: | Line 554: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Gastrointestinal tract|GI]] [[neoplasm]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Gastrointestinal tract|GI]] [[neoplasm]] | ||
| style="background: #F5F5F5; padding: 5px;" |>50 y/o | | style="background: #F5F5F5; padding: 5px; text-align: center;" |>50 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
(abdominal pain Intestinal obstruction and bleeding in small bowel cancer)? | (abdominal pain Intestinal obstruction and bleeding in small bowel cancer)? | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Anemia]] | * [[Anemia]] | ||
Line 582: | Line 582: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Renal]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pelvic kidney]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pelvic kidney]] | ||
| style="background: #F5F5F5; padding: 5px;" |NA | | style="background: #F5F5F5; padding: 5px; text-align: center;" |NA | ||
| style="background: #F5F5F5; padding: 5px;" |−/+ | | style="background: #F5F5F5; padding: 5px;" |−/+ | ||
* In case of sever hydronephrosis or renal stone we may have pelvic pain | * In case of sever hydronephrosis or renal stone we may have pelvic pain | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* In sonography we may see normal appearing kidney in pelvic position | * In sonography we may see normal appearing kidney in pelvic position | ||
Line 613: | Line 613: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* 40-50 y/o | * 40-50 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
Gastrointestinal symptoms, such as early satiety, obstruction | Gastrointestinal symptoms, such as early satiety, obstruction | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Mild leukocytosis. | * Mild leukocytosis. |
Revision as of 21:37, 29 January 2019
Ovarian cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ovarian cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Ovarian cancer differential diagnosis |
Risk calculators and risk factors for Ovarian cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Differentiating [Disease name] from other Diseases
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age of onset | Symptoms | Physical examination | ||||||||||||
Lab Findings | Imaging | Immunohistopathology | ||||||||||||
pelvic/abdominal pain or pressure | vaginal bleeding/discharge | GI dysturbance | Pleural effusion | Fever | Tenderness | CT scan/US | MRI | |||||||
Gynecologic | ||||||||||||||
Ovarian | Follicular cysts | – |
| |||||||||||
Theca lutein cysts | – |
|
| |||||||||||
Serous cystadenoma/carcinoma |
|
– |
|
| ||||||||||
Mucinous cystadenoma/carcinoma |
|
– |
| |||||||||||
Endometrioma | + | – |
|
|
|
|
|
| ||||||
Teratoma |
|
– |
|
| ||||||||||
Dysgerminoma | + | – |
|
|
|
| ||||||||
Choriocarcinoma |
|
– |
|
|
| |||||||||
Yolk sac tumor |
|
– |
|
|
|
| ||||||||
Fibroma |
|
– |
|
| ||||||||||
Thecoma |
|
– |
|
|||||||||||
Granulosa cell tumor |
|
|
– |
|
|
|
| |||||||
Sertoli-leydig cell tumor | – |
| ||||||||||||
Brenner tumor |
|
|
||||||||||||
Krukenberg tumor | + |
|
|
|||||||||||
Tubal | tubo-ovarian abscess | + | fever and vaginal discharge | |||||||||||
Ectopic pregnancy | ||||||||||||||
Hydrosalpinx | infertility | |||||||||||||
Tuberculosis salpingitis | +/– | |||||||||||||
Epithelial carcinoma | ||||||||||||||
serous tubal intraepithelial neoplasm | ||||||||||||||
Uterine | Myoma | |||||||||||||
Sarcoma | ||||||||||||||
Pregnancy | +/− | |||||||||||||
Non-gynecologic | ||||||||||||||
GIT | Appendiceal abscess | NA | + | – | + | + | +/– | + |
|
|
|
NA |
|
|
Appendiceal neoplasm[1] |
|
+ | – | + | + | – | +/– |
|
|
|
|
|
| |
Diverticular abscess | >50 y/o | + | – | + | + | +/– | + |
|
|
|
NA | Imaging/history |
| |
GI neoplasm | >50 y/o | + | – | +
(abdominal pain Intestinal obstruction and bleeding in small bowel cancer)? |
– | – | +/– |
|
|
|
|
|
| |
Renal | Pelvic kidney | NA | −/+
|
– | − | − | − | − | − |
|
|
|
|
|
Others | Retroperitoneal sarcoma[2] |
|
+ | – | +
Gastrointestinal symptoms, such as early satiety, obstruction |
− | − | − |
|
|
|
|
|
|
check sites of cancer that may metastasize to the ovaries (eg, stomach, colorectal, breast)
check rectum, liver, spleen, lungs, inguinal or supraclavicular lymph nodes for ovary metastase
References
- ↑ Chapter 5: Tumours of the Appendix - IARC. https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb2/bb2-chap5.pdf Accessed on January 15, 2019
- ↑ Storm FK, Mahvi DM (July 1991). "Diagnosis and management of retroperitoneal soft-tissue sarcoma". Ann. Surg. 214 (1): 2–10. PMC 1358407. PMID 2064467.